Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by NamesJebon Dec 20, 2020 9:25pm
214 Views
Post# 32150303

Can only manipulate so far

Can only manipulate so far
So I figured I'd bring this point up with all the recent negative comments regarding manipulation etc. I know some of the longs here look more thoroughly into who's trading what and when. I'm sure most people know about Kal aka Anonymous(assumed) who at all times has 100-200k on both the ask and bid between shares and warrants. The thing with predatory stock manipulators is they only have SO much pull. Sure the guy has 5-10 million shares and warrants, but we have to keep in mind there's 129+ million outstanding + warrants. If this final covid 19 data readout is in fact strong, someone with less than 8% ownership will simply not be able to keep it contained no matter how many shares they throw at the ask. If the data is strong we will blow past any attempts to keep this down so long as there is enough traction and interest.
<< Previous
Bullboard Posts
Next >>